<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01606683</url>
  </required_header>
  <id_info>
    <org_study_id>PLA-LENI-09 - SUBSTUDY 1</org_study_id>
    <nct_id>NCT01606683</nct_id>
  </id_info>
  <brief_title>Impact of Infant Feeding on Newborn Metabolomic Profile</brief_title>
  <official_title>Impact of Infant Feeding on Newborn Metabolomic Profile</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinz Italia SpA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cagliari</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heinz Italia SpA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the evaluation with untargeted modalities, of the urine
      metabolomic profile in a group of infants fed with a standard formula, a group of infants fed
      with a formula supplemented with functional ingredients and a group of breast-fed infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Metabolomics is of particular interest in the field of nutrition, since nutrients interact
      with a number of targets, metabolic pathways and functions.

      A suitable biofluid to study nutrient intake is urine, which is the most commonly used
      biological sample for metabolomic analysis and can be collected with simple and non-invasive
      methods.

      Up to now, no studies have investigated healthy term infants metabolome and its modulation
      according to different dietary regimens such as formula-feeding or breastfeeding.

      The aim of this study is to evaluate, with untargeted modalities, the urine metabolomic
      profile of a group of infants fed with a standard formula, a group of infants fed with a
      formula supplemented with functional ingredients and a group of breast-fed infants.

      Formula-fed infants participate to PLA-LENI-09 study (NCT01197365). We have included also a
      control group of breast-fed infants, as, from a scientific point of view, they represent the
      &quot;gold standard&quot; and no data are available on their metabolomic profile.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Metabolite patterns associated with different dietary regimens</measure>
    <time_frame>At enrolment, after 60 and 135 days of life</time_frame>
    <description>Urine will be analysed using 1H-NMR. Data will be analyzed through the use of software products to enable the discovery of hundreds of different metabolites involved in multiple pathways and connected with different conditions. The metabolites on which the univariate analysis will be performed are the most important revealed by the multivariate analysis (VIP variables) and Student's statistical test will be performed.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Formula Feeding of Healthy Full Term Infants</condition>
  <condition>Breast Feeding of Healthy Full Term Infants</condition>
  <arm_group>
    <arm_group_label>GROUP 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infant formula supplemented with with functional ingredients (galacto-oligosaccharides, beta-palmitate, fermented milk). Infant formula with functional ingredients is in compliance with Directive 2006/141/CE on infant formulae and follow-on formulae.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard infant formula, in compliance with Directive 2006/141/CE on infant formulae and follow-on formulae, without functional ingredients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Breast milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Infant formula with GOS, beta-palmitate, acidified milk</intervention_name>
    <description>Infant formula supplemented with functional ingredients (galacto-oligosaccharides, beta-palmitate, acidified milk.
Infant formula with functional ingredients is in compliance with Directive 2006/141/CE on infant formulae and follow-on formulae.</description>
    <arm_group_label>GROUP 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard infant formula without functional ingredients</intervention_name>
    <description>Standard infant formula, in compliance with Directive 2006/141/CE on infant formulae and follow-on formulae, without functional ingredients.</description>
    <arm_group_label>GROUP 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>CONTROL GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants being exclusively either breastfed or formula-fed by the 21st day of life

          -  Infants of both sexes born with natural or caesarian delivery

          -  Gestational age between 37 and 42 completed weeks

          -  Birth weight between 10th and 90th percentile of birth weight for gestational age,
             according to the North-Italian growth charts

          -  Single birth

          -  Caucasian parents

        Exclusion Criteria:

          -  Infants with genetic and/or congenital diseases

          -  Infants receiving antibiotic therapy

          -  Infants with neonatal diseases requiring hospitalisation for longer than 7 days

          -  Infants at risk for atopy and/or having familial history for atopy

          -  Mothers with metabolic or chronic diseases

          -  Infant selected for another clinical study

          -  Parents refusing to sign a written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro Stronati, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>FONDAZIONE IRCCS POLICLINICO &quot;SAN MATTEO&quot; - STRUTTURA COMPLESSA DI NEONATOLOGIA, PATOLOGIA NEONATALE E TERAPIA INTENSIVA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondazione Irccs Policlinico &quot;San Matteo&quot; - Struttura Complessa Di Neonatologia, Patologia Neonatale E Terapia Intensiva</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 2004 May;22(5):245-52. Review.</citation>
    <PMID>15109811</PMID>
  </reference>
  <reference>
    <citation>Ryan D, Robards K. Metabolomics: The greatest omics of them all? Anal Chem. 2006 Dec 1;78(23):7954-8.</citation>
    <PMID>17134127</PMID>
  </reference>
  <reference>
    <citation>Fanos V, Barberini L, Antonucci R, Atzori L. Metabolomics in neonatology and pediatrics. Clin Biochem. 2011 May;44(7):452-4. doi: 10.1016/j.clinbiochem.2011.03.006.</citation>
    <PMID>22036322</PMID>
  </reference>
  <reference>
    <citation>Atzori L, Antonucci R, Barberini L, Griffin JL, Fanos V. Metabolomics: a new tool for the neonatologist. J Matern Fetal Neonatal Med. 2009;22 Suppl 3:50-3. doi: 10.1080/14767050903181500. Review.</citation>
    <PMID>19701858</PMID>
  </reference>
  <reference>
    <citation>Goodacre R. Metabolomics of a superorganism. J Nutr. 2007 Jan;137(1 Suppl):259S-266S. doi: 10.1093/jn/137.1.259S. Review.</citation>
    <PMID>17182837</PMID>
  </reference>
  <reference>
    <citation>Nicholson JK, Wilson ID. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003 Aug;2(8):668-76. doi: 10.1038/nrd1157. Review.</citation>
    <PMID>12904817</PMID>
  </reference>
  <reference>
    <citation>Nicholson JK, Holmes E, Lindon JC, Wilson ID. The challenges of modeling mammalian biocomplexity. Nat Biotechnol. 2004 Oct;22(10):1268-74. Review.</citation>
    <PMID>15470467</PMID>
  </reference>
  <reference>
    <citation>Carraro S, Giordano G, Reniero F, Perilongo G, Baraldi E. Metabolomics: a new frontier for research in pediatrics. J Pediatr. 2009 May;154(5):638-44. doi: 10.1016/j.jpeds.2009.01.014.</citation>
    <PMID>19364557</PMID>
  </reference>
  <reference>
    <citation>Janečková H, Hron K, Wojtowicz P, Hlídková E, Barešová A, Friedecký D, Zídková L, Hornik P, Behúlová D, Procházková D, Vinohradská H, Pešková K, Bruheim P, Smolka V, Sťastná S, Adam T. Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders. J Chromatogr A. 2012 Feb 24;1226:11-7. doi: 10.1016/j.chroma.2011.09.074. Epub 2011 Oct 4.</citation>
    <PMID>22018716</PMID>
  </reference>
  <reference>
    <citation>Atzori L, Antonucci R, Barberini L, Locci E, Cesare Marincola F, Scano P, Cortesi P, Agostiniani R, Weljie A, Lai A, Fanos V. 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front Biosci (Elite Ed). 2010 Jan 1;2:725-32.</citation>
    <PMID>20036916</PMID>
  </reference>
  <reference>
    <citation>Atzori L, Antonucci R, Barberini L, Locci E, Marincola FC, Scano P, Cortesi P, Agostiniani R, Defraia R, Weljie A, Gazzolo D, Lai A, Fanos V. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed). 2011 Jun 1;3:1005-12.</citation>
    <PMID>21622109</PMID>
  </reference>
  <reference>
    <citation>Ciccarelli S, Atzori L, Noto A, Barberini L, Fanos V, Caramia G, Agostino R. Spontaneous vs cesarean delivery: a metabolomic point of view. J Matern Fetal Neonatal Med 24(S(2):1-2, 2011.</citation>
  </reference>
  <reference>
    <citation>Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics. 2009 Dec;5(4):435-458. Epub 2009 Jun 12.</citation>
    <PMID>20046865</PMID>
  </reference>
  <reference>
    <citation>Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B. Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr. 2005 Sep;82(3):497-503. Review.</citation>
    <PMID>16155259</PMID>
  </reference>
  <reference>
    <citation>Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr. 2006 Sep;84(3):531-9.</citation>
    <PMID>16960166</PMID>
  </reference>
  <reference>
    <citation>Phipps AN, Stewart J, Wright B, Wilson ID. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica. 1998 May;28(5):527-37.</citation>
    <PMID>9622854</PMID>
  </reference>
  <reference>
    <citation>Bell JD, Sadler PJ, Morris VC, Levander OA. Effect of aging and diet on proton NMR spectra of rat urine. Magn Reson Med. 1991 Feb;17(2):414-22.</citation>
    <PMID>1829498</PMID>
  </reference>
  <reference>
    <citation>Zhang X, Yap Y, Wei D, Chen G, Chen F. Novel omics technologies in nutrition research. Biotechnol Adv. 2008 Mar-Apr;26(2):169-76. doi: 10.1016/j.biotechadv.2007.11.002. Epub 2007 Nov 19. Review.</citation>
    <PMID>18164161</PMID>
  </reference>
  <reference>
    <citation>Bertram HC, Hoppe C, Petersen BO, Duus JØ, Mølgaard C, Michaelsen KF. An NMR-based metabonomic investigation on effects of milk and meat protein diets given to 8-year-old boys. Br J Nutr. 2007 Apr;97(4):758-63.</citation>
    <PMID>17349089</PMID>
  </reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2012</study_first_submitted>
  <study_first_submitted_qc>May 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2012</study_first_posted>
  <last_update_submitted>February 2, 2015</last_update_submitted>
  <last_update_submitted_qc>February 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acidified milk</keyword>
  <keyword>Beta-palmitate</keyword>
  <keyword>Bifidobacteria</keyword>
  <keyword>Breastfeeding</keyword>
  <keyword>Infant formula</keyword>
  <keyword>Galacto-oligosaccharides</keyword>
  <keyword>Growth</keyword>
  <keyword>Infants</keyword>
  <keyword>Metabolomics</keyword>
  <keyword>Prebiotics</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

